Re: Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery

被引：0
|
作者：
van den Bergh, Roderick C. N. [1 ]
Zargar, Homayoun [1 ]
Murphy, Declan G. [1 ]
机构：
[1] Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
来源：
EUROPEAN UROLOGY | 2016年 / 69卷 / 05期
关键词：
RADICAL PROSTATECTOMY;
D O I：
10.1016/j.eururo.2016.02.011
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：964 / 965
页数：3
相关论文
共 50 条
  • [1] Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery
    Tosoian, Jeffrey J.
    Sundi, Debasish
    Trock, Bruce J.
    Landis, Patricia
    Epstein, Jonathan I.
    Schaeffer, Edward M.
    Carter, H. Ballentine
    Mamawala, Mufaddal
    [J]. EUROPEAN UROLOGY, 2016, 69 (04) : 576 - 581
  • [2] COMPARISON OF PATHOLOGIC OUTCOMES IN MEN WITH FAVORABLE-RISK PROSTATE CANCER UNDERGOING DELAYED SURGERY AFTER ACTIVE SURVEILLANCE VERSUS IMMEDIATE SURGERY
    Tosoian, Jeffrey
    Sundi, Debasish
    Trock, Bruce
    Landis, Patricia
    Epstein, Jonathan
    Schaeffer, Edward
    Mamawala, Mufaddal
    Carter, H. Ballentine
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E757 - E758
  • [3] Re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576-81
    Yan, Weigang
    Zhou, Zhien
    Li, Hanzhong
    [J]. EUROPEAN UROLOGY, 2017, 71 (01) : E12 - E12
  • [4] Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer
    Radhakrishnan, Archana
    Wallner, Lauren P.
    Skolarus, Ted A.
    George, Arvin K.
    Rosenberg, Bradley H.
    Abrahamse, Paul
    Hawley, Sarah T.
    [J]. JOURNAL OF UROLOGY, 2022, 208 (03): : 600 - 608
  • [5] Thoughts on Criteria for Active Surveillance of Favorable-risk Prostate Cancer
    Gettman, Matthew T.
    [J]. EUROPEAN UROLOGY, 2016, 70 (06) : 961 - 962
  • [6] THE IMPACT OF CONFIRMATORY TESTING ON THE ADOPTION OF ACTIVE SURVEILLANCE FOR MEN WITH FAVORABLE-RISK PROSTATE CANCER
    Kaye, Deborah
    Qi, Ji
    Morgan, Todd
    Linsell, Susan
    Lane, Brian
    Montie, James
    Miller, David
    Cher, Michael
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E205 - E205
  • [7] Active Surveillance for Favorable-Risk Prostate Cancer: A Short Review
    Lawrentschuk, Nathan
    Klotz, Laurence
    [J]. KOREAN JOURNAL OF UROLOGY, 2010, 51 (10) : 665 - 670
  • [8] ACTIVE SURVEILLANCE FOR FAVORABLE-RISK PROSTATE CANCER IN AFRICAN CARIBBEAN MEN: RESULTS OF A PROSPECTIVE STUDY
    Meunier, Matthias
    Eyraud, Remi
    Senechal, Cedric
    Gourtaud, Gilles
    Roux, Virginie
    Lanchon, Cecilia
    Brureau, Laurent
    Blanchet, Pascal
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E561 - E562
  • [9] Active surveillance for favorable-risk prostate cancer: who, how and why?
    Klotz, Laurence
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (12): : 692 - 698
  • [10] Active surveillance for favorable-risk prostate cancer: who, how and why?
    Laurence Klotz
    [J]. Nature Clinical Practice Oncology, 2007, 4 : 692 - 698
12345